PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Hofer, T.P. ; van de Loosdrecht, A.* ; Stahl-Hennig, C.* ; Cassatella, M.A.* ; Ziegler-Heitbrock, L.*

6-sulfo LacNAc (Slan) as a marker for non-classical monocytes.

Front. Immunol. 10:2052 (2019)
Verlagsversion DOI
Open Access Gold
Creative Commons Lizenzvertrag
Copyright © 2019 Hofer, van de Loosdrecht, Stahl-Hennig, Cassatella and Ziegler-Heitbrock. Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Slan is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
4.716
1.092
15
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Cancer ; Cmml ; Inflammation ; Lymphoma ; Man ; Monkey ; Monocyte Subsets ; Slan
Sprache englisch
Veröffentlichungsjahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 1664-3224
e-ISSN 1664-3224
Zeitschrift Frontiers in Immunology
Quellenangaben Band: 10, Heft: , Seiten: , Artikelnummer: 2052 Supplement: ,
Verlag Frontiers
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502710-001
G-501760-002
DOI 10.3389/fimmu.2019.02052
Scopus ID 85072761212
Erfassungsdatum 2019-09-19
[➜Korrektur melden]